| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
This compound does not have a biological target. It acts as a chemical linker that joins a target-binding ligand and an E3 ligase ligand to form a PROTAC. The azide and carboxylic acid groups are reactive handles for orthogonal conjugation, not for binding to biological receptors.
|
|---|---|
| ln Vitro |
The reagent itself shows no in vitro activity. It is a building block for PROTACs, which are tested in cell-free and cellular assays for target degradation. The linker's length and hydrophilicity can modulate the efficiency of PROTAC-mediated degradation.
|
| ln Vivo |
No intrinsic in vivo activity. When incorporated into a PROTAC, the resulting molecule may exhibit in vivo efficacy by degrading target proteins. The PEG16 spacer enhances solubility and circulation time, potentially improving the pharmacokinetic profile of the PROTAC.
|
| Enzyme Assay |
Not applicable to this linker alone. It is used in synthesis, and the final PROTAC is subjected to binding assays to confirm target engagement. No standard protocol exists for testing the linker in enzyme or receptor binding experiments.
|
| Cell Assay |
No direct cell assay for the linker. It is used to prepare PROTACs, which are then evaluated in cell-based assays for protein degradation, viability, and signaling changes. The linker itself is not added to cells.
|
| Animal Protocol |
No in vivo procedure is performed with this linker alone. It is a precursor for PROTACs, which are administered to animals to assess efficacy, pharmacokinetics, and safety. The linker's properties influence the biodistribution of the final PROTAC.
|
| References |
| CAS # |
3080184-80-8
|
|---|---|
| Appearance |
Typically exists as solid at room temperature
|
| Synonyms |
AzidoPEG16acid; Azido PEG16 acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.